Control strategy for replication competent AAV formation in AAV manufacturing
08 Sept 2026
Gene Therapy Manufacturing
- Latest agency position on presence of rcAAV residual in Drug substance
- Creative approaches for minimizing impact to programs
- Detection and control strategies
- What can this industry do to minimize rcAAV formation in manufacturing process
